drugset / Trial / NCT04821687
A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD
RandomizedParallel-groupOpen-labelTreatment
Summary
A Study to evaluate the add-on efficacy and safety of opicapone 50 mg or an extra dose of L-DOPA 100 mg for the treatment of wearing-off in patients with PD.
Timeline
- Start
- 2021-06-17
- Primary completion
- 2022-08-18
- Completion
- 2022-08-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Madopar Tab. 125 or Perkin Tab. 25-100mg | Unknown | 100 mg | — |
| Subject | Opicapone | Small molecule | 50 mg | — |